Rafferty Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,114
| Closed | -$730K | – | 1076 |
|
|
2023
Q2 | $730K | Sell |
28,114
-878
| -3% | -$22.8K | ﹤0.01% | 898 |
|
|
2023
Q1 | $833K | Buy |
28,992
+880
| +3% | +$25.3K | 0.01% | 844 |
|
|
2022
Q4 | $832K | Sell |
28,112
-240
| -0.8% | -$7.1K | 0.01% | 799 |
|
|
2022
Q3 | $675K | Buy |
28,352
+14,210
| +100% | +$338K | 0.01% | 788 |
|
|
2022
Q2 | $316K | Sell |
14,142
-15,499
| -52% | -$346K | ﹤0.01% | 906 |
|
|
2022
Q1 | $744K | Buy |
29,641
+6,363
| +27% | +$160K | ﹤0.01% | 842 |
|
|
2021
Q4 | $834K | Buy |
23,278
+8,586
| +58% | +$308K | ﹤0.01% | 951 |
|
|
2021
Q3 | $625K | Sell |
14,692
-6,025
| -29% | -$256K | ﹤0.01% | 994 |
|
|
2021
Q2 | $897K | Sell |
20,717
-7,774
| -27% | -$337K | 0.01% | 952 |
|
|
2021
Q1 | $1.16M | Buy |
28,491
+23,112
| +430% | +$943K | 0.01% | 740 |
|
|
2020
Q4 | $243K | Sell |
5,379
-6,512
| -55% | -$294K | ﹤0.01% | 922 |
|
|
2020
Q3 | $421K | Buy |
11,891
+4,549
| +62% | +$161K | 0.01% | 736 |
|
|
2020
Q2 | $277K | Buy |
+7,342
| New | +$277K | ﹤0.01% | 850 |
|
|
2020
Q1 | – | Sell |
-18,719
| Closed | -$971K | – | 609 |
|
|
2019
Q4 | $971K | Sell |
18,719
-5,192
| -22% | -$269K | 0.01% | 560 |
|
|
2019
Q3 | $1.31M | Buy |
23,911
+1,145
| +5% | +$62.8K | 0.02% | 482 |
|
|
2019
Q2 | $925K | Buy |
22,766
+2,108
| +10% | +$85.7K | 0.02% | 571 |
|
|
2019
Q1 | $625K | Buy |
+20,658
| New | +$625K | 0.01% | 626 |
|